European Healthtech startup funding raised during Q2 2024.
In Q2 2024, 99 European Healthtech companies raised a combined €1.3B across 99 funding rounds, down 0.2% versus Q2 2023. UK led by capital raised, and Elaia was the most active investor. Data as of 9 Jul 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Bicycle Therapeutics | Other | May 2024 | €512M |
| iOnctura | Series B | Jun 2024 | €80M |
| Oculis | Other | Apr 2024 | €55M |
| Natural Cycles | Series C | May 2024 |
| €51M |
| Uromems | Series C | Jun 2024 | €44M |
| Grey Wolf Therapeutics | Series B | May 2024 | €42M |
| LabGenius | Other | May 2024 | €41M |
| Enifer | Series B | May 2024 | €36M |
| Resilience | Other | May 2024 | €23M |
| Smart Reporting | Series C | Apr 2024 | €23M |
| Biofidelity | Other | Apr 2024 | €22M |
| Memo Therapeutics | Series C | May 2024 | €20M |
| Vitestro | Other | Apr 2024 | €20M |
| Cn Bio Innovations | Series B | Apr 2024 | €20M |
| Insempra | Series A | May 2024 | €19M |
